- Investing Ideas
- Danish Pharmaceuticals & Biotech Healthy potentially undervalued
Danish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
3
0 new
Companies which are potentially undervalued and in an acceptable financial position.
3 companies
Bavarian Nordic
Market Cap: DKK 14.9b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 194.70
7D
3.3%
1Y
27.1%
Novo Nordisk
Market Cap: DKK 1.0t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 234.30
7D
-1.6%
1Y
-51.1%
H. Lundbeck
Market Cap: DKK 37.6b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 40.14
7D
6.6%
1Y
19.6%